ConductScience.org, home

Comparison · NCT01993667-cef21e72

Acetazolamide Normal Dose vs Acetazolamide Low Dose: Number of Participants With Side Effects

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Acetazolamide Normal Dose vs Acetazolamide Low Dose: Number of Participants With Side Effects. Trial comparisons, record NCT01993667-cef21e72. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01993667-cef21e72

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1710.0810.327wilson
Risk in group 20.1840.09220.334wilson
Risk difference, group 1 minus group 2-0.0128-0.1880.168newcombe hybrid score
Risk ratio, group 1 over group 20.9310.3462.5log
Odds ratio, group 1 over group 20.9160.2753.05log
Number needed to treat, for one fewer participant with the outcome on Acetazolamide Normal Dose than on Acetazolamide Low Dose78.2from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Acetazolamide Normal DoseExperimental : Acetazolamide 125 mg twice daily~Acetazolamide: Administration of low dose acetazolamide635OG000
Group 2Acetazolamide Low DoseExperimental: Acetazolamide 62.5 mg twice daily~Acetazolamide: Administration of low dose acetazolamide738OG001

Outcome

Type
SECONDARY
Title
Number of Participants With Side Effects
Description
The typical side effects of acetazolamide will be measured daily (paresthesias of fingers and toes, change in urination frequency, and change in taste of beverages).~The side effect questionnaire included the following questions: In the past 12 h, have you experienced the following symptoms: Tingling of toes? Tingling of fingers? Increase in urination? Taste change of beverages? Symptoms were self-reported and rated on a 0-5 scale (0=none, 5=maximum)
Time frame
12 days
Population
These participants had sufficient data to be included in the analysis.

Source ClinicalTrials.gov

Trial

Title
Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing
NCT number
NCT01993667
Phases
PHASE4
Conditions
Prophylaxis of Acute Mountain Sickness
Interventions
Low Dose Acetazolamide, Normal Dose Acetazolamide
Lead sponsor
University of Utah
Results first posted
2019-01-29

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01993667-cef21e72